Clicky

Tonghua Dongbao Pharmaceutical Co Ltd(600867)

Description: Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.


Keywords: Building Materials Pharmaceutical Products Diabetes Medical Device Insulin Endocrine System Peptide Hormones Recombinant Proteins Endocrinology Treatment Of Diabetes Insulin Glargine Anti Diabetic Medication Insulin Lispro Insulin Aspart Tonghua

Home Page: www.thdb.com

Dongbao New Village
Tonghua, 134123
China
Phone: 86 43 5508 8025


Officers

Name Title
Mr. Sheng Leng Chun Chairman & GM
Mr. Hong Chen Chief Engineer and Deputy Gen. Mang.
Mr. Junyu Chi Chief Accountant
Mr. Guodong Zhang Deputy GM & Director
Mr. Wenhai Zhang Deputy GM & Director
Ms. Fan Su Deputy GM & Board Sec.

Exchange: SHG

Country: CN

Currency: Renminbi (¥)

Forward PE: 20.6186
Trailing PE: 11.9024
Price-to-Book MRQ: 2.9695
Price-to-Sales TTM: 6.5042
IPO Date: 1994-06-30
Fiscal Year End: December
Full Time Employees: 0
Back to stocks